A novel mitochondrial MTND5 frameshift mutation causing isolated complex I deficiency, renal failure and myopathy
Received 20 July 2009; received in revised form 23 October 2009; accepted 26 October 2009.
Abstract
Isolated complex I deficiency is the most commonly reported enzyme defect in paediatric mitochondrial disorders, and may arise due to mutations in nuclear-encoded structural or assembly genes, or the mitochondrial genome. We present the clinical, biochemical and molecular genetic data in a young girl whose clinical picture is dominated by chronic renal failure, myopathy and persistent lactic acidosis. An isolated complex I deficiency in muscle was identified due to a novel mutation (m.12425delA) in the MTND5 gene. This single nucleotide deletion is heteroplasmic and detectable in several tissues from the proband but not her mother, suggesting a de novo mutation event. The description of the first frameshift mutation in a mitochondrial complex I gene affirms mitochondrial DNA mutations as an important cause of isolated complex I deficiency in children and the importance of whole mitochondrial genome sequencing in the diagnostic work-up to elucidate the underlying molecular genetic abnormality and provide important genetic advice.
aMitochondrial Research Group and NCG Rare Mitochondrial Disorders of Adults and Children Service, Newcastle University, Newcastle upon Tyne, UK
bUniversity Hospital of the Ludwig-Maximilians-University, Campus Innenstadt, Munich, Germany
cMGZ – Center of Medical Genetics, Munich, Germany
dDepartment of Paediatric Nephrology, Evelina Children’s Hospital, Guys & St. Thomas’ NHS Foundation Trust, London, UK
eNeurometabolic Unit, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK
fChemical Pathology, Great Ormond Street Hospital, London, UK
gCentre for Inherited Metabolic Disease, Guys & St. Thomas’ NHS Foundation Trust, London, UK
Corresponding author. Address: Mitochondrial Research Group, Institute for Ageing and Health, The Medical School, Newcastle University, Framlington Place, Newcastle upon Tyne NE2 4HH, UK. Tel.: +44 191 2223685; fax: +44 191 2824373.